Financial Performance - Lakeland Financial reported $63.8 million in revenue for the quarter ended March 2025, a year-over-year increase of 6.3% [1] - The reported revenue exceeded the Zacks Consensus Estimate of $62.3 million by 2.41% [1] - Earnings per share (EPS) for the quarter was $0.78, down from $0.88 a year ago, representing a surprise of -10.34% compared to the consensus EPS estimate of $0.87 [1] Key Metrics - Net Interest Margin was reported at 3.4%, slightly above the two-analyst average estimate of 3.3% [4] - The Efficiency Ratio was 51.4%, compared to the average estimate of 51% by two analysts [4] - Total Noninterest Income was $10.93 million, below the average estimate of $11.70 million based on two analysts [4] Stock Performance - Shares of Lakeland Financial have returned -10.1% over the past month, while the Zacks S&P 500 composite experienced a -4.8% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

HCA Healthcare (HCA) reported $18.32 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 5.7%. EPS of $6.45 for the same period compares to $5.36 a year ago.The reported revenue represents a surprise of +0.08% over the Zacks Consensus Estimate of $18.31 billion. With the consensus EPS estimate being $5.77, the EPS surprise was +11.79%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determi ...

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.3100 | 0.3300 | -6.06 | 0.4900 | | 每股净资产（元） | 13.45 | 18.87 | -28.72 | 9.69 | | 每股公积金(元) | 7.45 | 11.22 | -33.6 | 2.05 | | 每股未分配利润(元) | 4.70 | 6.01 | -21.8 | 5.80 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.18 | 1.16 | 1.72 | 1.07 | | 净利润(亿元) | 0.31 | 0.33 | -6.06 | 0.25 | | 净资产收益率(%) | 2.29 | 2.64 | -13.26 | 5.19 | 数据四舍五入，查看更多财务数据>> | 名称 | 持有数量(万股) | 占总股本比 | 增减情况 | | --- | --- | --- | - ...

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.1400 | -0.1600 | 12.5 | -0.1200 | | 每股净资产（元） | 3.7 | 4.24 | -12.74 | 5.23 | | 每股公积金(元) | 3.85 | 3.84 | 0.26 | 3.84 | | 每股未分配利润(元) | -1.29 | -0.72 | -79.17 | 0.27 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 7.7 | 4.69 | 64.18 | 13.86 | | 净利润(亿元) | -1.87 | -2.12 | 11.79 | -1.67 | | 净资产收益率(%) | -3.73 | -3.67 | -1.63 | -2.36 | 数据四舍五入，查看更多财务数据>> 前十大流通股东累计持有： 87891.84万股，累计占流通股比： 65.93%，较上期变化： 1 ...

一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.1600 | 0.4126 | -61.22 | 1.9758 | | 每股净资产（元） | 4.16 | 4.12 | 0.97 | 4.66 | | 每股公积金(元) | 1.36 | 1.36 | 0 | 0.87 | | 每股未分配利润(元) | 1.60 | 1.55 | 3.23 | 2.51 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 16.03 | 20.49 | -21.77 | 20.84 | | 净利润(亿元) | 0.94 | 2.31 | -59.31 | 6.3 | | 净资产收益率(%) | 3.86 | 10.47 | -63.13 | 53.84 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 17166.46万股，累计占流通股比： 54.14%，较 ...

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0929 | 0.0856 | 8.53 | 0.0807 | | 每股净资产（元） | 2.31 | 1.94 | 19.07 | 1.79 | | 每股公积金(元) | 0.31 | 0.31 | 0 | 0.3 | | 每股未分配利润(元) | 0.93 | 0.59 | 57.63 | 0.46 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 62.74 | 53.71 | 16.81 | 46.39 | | 净利润(亿元) | 2.11 | 1.94 | 8.76 | 1.83 | | 净资产收益率(%) | 4.08 | 4.46 | -8.52 | 4.57 | 前十大流通股东累计持有： 175250.46万股，累计占流通股比： 77.21%，较上期变 化： -580.55万股。 | 名称 | 持有数量(万股) | 占总 ...

前十大流通股东累计持有： 53911.25万股，累计占流通股比： 48.09%，较上期变化： 592.87万股。 一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.0311 | -0.0002 | -15450 | -0.0090 | | 每股净资产（元） | 2.3 | 2.5 | -8 | 2.44 | | 每股公积金(元) | 0.63 | 0.66 | -4.55 | 0.66 | | 每股未分配利润(元) | 0.51 | 0.76 | -32.89 | 0.71 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 3.2 | 3.99 | -19.8 | 4.25 | | 净利润(亿元) | -0.35 | 0 | 0 | -0.1 | | 净资产收益率(%) | -1.35 | -0.01 | -13400 | -0.36 | 数据四舍五入，查看更多财务数据>> 二、前1 ...

Financial Performance - The company reported a basic earnings per share of -0.0332 yuan for Q1 2025, an improvement of 37.59% compared to -0.0532 yuan in Q1 2024 [1] - Revenue for Q1 2025 was 1.52 billion yuan, representing a 31.03% increase from 1.16 billion yuan in Q1 2024 [1] - The net profit for Q1 2025 was -0.25 billion yuan, showing a 37.5% improvement from -0.4 billion yuan in Q1 2024 [1] - The return on equity for Q1 2025 was -1.60%, an improvement of 33.05% compared to -2.39% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 73.1321 million shares, accounting for 12.05% of the circulating shares, with a decrease of 3.5647 million shares from the previous period [1] - Notable shareholders include 廖定海 with 35.0705 million shares (5.78%) and 廖文 with 10.8374 million shares (1.79%), both remaining unchanged [2] - Hong Kong Central Clearing Limited decreased its holdings by 3.4026 million shares to 7.1084 million shares (1.17%) [2] Dividend Policy - The company has announced that it will not distribute dividends or bonus shares this time [3]

Financial Performance - The company reported a basic earnings per share of 0.1700 yuan for Q1 2025, representing a 13.33% increase compared to 0.1500 yuan in Q1 2024 [1] - The net profit for Q1 2025 was 0.96 billion yuan, up 17.07% from 0.82 billion yuan in Q1 2024 [1] - The operating revenue for Q1 2025 reached 6.27 billion yuan, a 23.18% increase from 5.09 billion yuan in Q1 2024 [1] - The return on equity decreased to 2.80% in Q1 2025 from 3.63% in Q1 2024, a decline of 22.87% [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 13,313.51 million shares, accounting for 24.34% of the circulating shares, which is a decrease of 305.19 million shares from the previous period [1] - Notable shareholders include Shen Jie with 5,613.61 million shares (10.26%), and Nanjing University Capital Operation Co., Ltd. with 1,909.00 million shares (3.49%) [2] - New entrants among the top shareholders include China Industrial Bank's ETF with 1,247.92 million shares (2.28%) [2] Dividend Distribution - The company has announced that there will be no distribution or transfer of dividends this time [3]

近期福安药业（300194）发布2025年一季报，证券之星财报模型分析如下： 经营业绩 近期福安药业发布的2025年一季报显示，公司业绩出现明显下滑。具体来看，截至本报告期末，公司营 业总收入为4.68亿元，同比下降42.22%；归母净利润为6904.9万元，同比下降43.63%；扣非净利润为 6568.48万元，同比下降43.8%。 单季度数据 主营分类 主营构成 主营收入 收入占比 主营利润 利润占比 毛利率 财务分析 业务评价 证券之星价投圈财报分析工具显示，公司去年的ROIC为5.36%，近年资本回报率一般。公司业绩具有周 期性。去年的净利率为11.63%，算上全部成本后，公司产品或服务的附加值一般。 从单季度数据来看，2025年第一季度营业总收入为4.68亿元，同比下降42.22%；归母净利润为6904.9万 元，同比下降43.63%；扣非净利润为6568.48万元，同比下降43.8%。 主要财务指标 本次财报公布的各项数据指标表现不尽如人意。具体如下： 主营收入构成 根据财报，福安药业的主营收入构成如下表所示： 融资分红 公司自上市以来，累计融资总额为34.66亿元，累计分红总额为6.05亿元，分 ...